Navigation Links
New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
Date:10/15/2007

PHILADELPHIA, Oct. 15 /PRNewswire-FirstCall/ -- Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ) ulcerative colitis (UC) drug LIALDA(TM) (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis. These analyses of LIALDA's 303 trial, a long-term, Phase III, open-label 12-14 month extension study, are being presented this week at The American College of Gastroenterology (ACG) meeting in Philadelphia.

The primary endpoint of study 303 was safety and tolerability and findings -- that LIALDA is generally well tolerated in mild to moderate UC patients -- were presented at the British Society of Gastroenterology (BSG) meeting in Glasgow, Scotland in March 2007.

"Earlier studies showed that LIALDA is well-tolerated and effective at inducing remission in patients with active, mild to moderate UC. Post-hoc analysis of secondary endpoints provided evidence that LIALDA maintained remission in a variety of UC patients," said Gary R. Lichtenstein, M.D., director of the Center for Inflammatory Bowel Diseases at the Hospital of the University of Pennsylvania.

A summary of key scientific presentations of post-hoc analyses of secondary endpoints of study 303 follows.

Once or Twice Daily LIALDA for Mild vs. Moderate Ulcerative Colitis

Poster Presentation: Tuesday, October 16, 2007, Exhibit Hall B, #950

A post-hoc analysis of secondary endpoints from the long-term 303 study was performed to review the efficacy of LIALDA for maintaining remission in patients with mild versus moderate ulcerative colitis. In the 303 study, patients were randomized to receive LIALDA 2.4g/day (given once daily [QD]) or 2.4g/day (1.2g given twice daily [BID]). Study 303 defined patient remission using stringent clinical and endoscopic measures: modified UC Disease Activity Index (UC-DAI) score of less than or equal to 1 with score
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
2. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
3. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Data Analyses Outline Efficacy and Safety of Mircera for the Treatment of Renal Anemia Associated With Chronic Kidney Disease
5. Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
6. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
7. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
8. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
9. 8-Year Long-term Data Demonstrate Prolonged Overall Survival and Length of Disease Remission with Bexxar
10. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
11. Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 2014  Remedy Informatics, the leading provider of ... life sciences research, announced that it has teamed ... build the first-ever national patient registry devoted to ... "The National Pancreas Foundation is a ... and committed organizations can effect upon society as ...
(Date:7/14/2014)... , July 14, 2014  Celsion Corporation (NASDAQ: ... that the Company will ring the NASDAQ Stock Market closing ... New York, NY . President ... the Celsion and EGEN management teams will participate in the ... ET.  A live webcast will be available at https://new.livestream.com/nasdaq/live ...
(Date:7/14/2014)... Minn. , July 14, 2014  Today, ATS ... announced that it acquired the assets of MicroTest Labs, ... The acquisition of MTL is the first step in ... chemistry laboratory services platform to support the medical device ... known as Accuratus Lab Services , a name ...
Breaking Medicine Technology:Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 2Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 3Celsion Corporation to Ring the NASDAQ Stock Market Closing Bell on July 16, 2014 2Celsion Corporation to Ring the NASDAQ Stock Market Closing Bell on July 16, 2014 3ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc. 2ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc. 3
... /PRNewswire-iReach/ -- Today Enroute Systems Corporation ... last mile postal service delivery service options for its ... existing support of multiple global and regional carrier parcel ... businesses and residences in over 220 countries through their ...
... 31, 2012 Medical Alarm Concepts Holding, Inc. (OTCQB: ... subsequent order as part of a large ongoing commitment ... purchase order, which will be delivered in monthly installments ... date. "In November 2011, we announced a ...
Cached Medicine Technology:Enroute Adds Last Mile Postal Service Delivery Services 2Enroute Adds Last Mile Postal Service Delivery Services 3Medical Alarm to Begin Fulfillment of MediPendant™ Against Largest Purchase Order - Announces Additional Warrant Cancellations 2Medical Alarm to Begin Fulfillment of MediPendant™ Against Largest Purchase Order - Announces Additional Warrant Cancellations 3Medical Alarm to Begin Fulfillment of MediPendant™ Against Largest Purchase Order - Announces Additional Warrant Cancellations 4
(Date:7/14/2014)... 14, 2014 Documented Legacy , a ... the publication of its first military memoir about a World ... Thursday in October 1943 and 19 months as a prisoner ... and build the American dream. , From the Top ... dream (Amazon) is a true life story of ...
(Date:7/14/2014)... 14, 2014 Seven promising startup ... healthcare problems have been accepted into the ... Accelerator (DHA). , The awardees were selected ... multi-stage process. They include Biomeme, Fitly, Life Patch, ... (from France) and Pulse InfoFrame (from Canada) —both ...
(Date:7/14/2014)... 2014 According to a new market ... (GaN, SiC, and Others), Devices (Power IC, Power Module ... Forecast to 2014 - 2020", the Power Electronics market ... power electronics market is valued at $36.86 Billion and ... 2014- 2020. The report also includes an in-depth analysis ...
(Date:7/14/2014)... Dallas, TX (PRWEB) July 14, 2014 ... transcatheter heart valves market in Americas. The analysis ... over the 2007–2020 period and key company share ... countries: US, Canada, Brazil and Mexico. It uses ... and secondary research and in-house analysis. , Scope, ...
(Date:7/14/2014)... July 13, 2014 (HealthDay News) -- Along with improving ... with Alzheimer,s disease and other types of dementia, a ... quality of life, the researchers said. "These preliminary ... of benefits for people with dementia and their loved ... of Case Western Reserve University and University Hospitals Case ...
Breaking Medicine News(10 mins):Health News:Mount Laurel-based Documented Legacy to Release Military Memoir of World War II Air Force Vet Who Survived Black Thursday Crash 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 3Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 4Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 2Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 3Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 4Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 5Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 2Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 3Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 4Health News:Cataract Surgery a Plus for Someone With Dementia, Study Says 2
... the McEwen Centre for Regenerative Medicine, Toronto General Hospital, researchers ... specific repair cells from the bone marrow to the affected ... been known that bone marrow cells have the ability to ... not been known until now is the critically important role ...
... that analyzed nearly 22,000 U.S men for a good 14 ... and keeping tabs on the body weight has an impact ... , ,Dr. Eric B. Rimm, co-author of the study, said ... be psychological, it has become clear that heart disease and ...
... Squibb has announced the launch of BARACLUDE? (entecavir) ... //following its approval by the Drug Controller General of ... treatment of chronic hepatitis B virus infection in adults ... of persistent elevations in serum aminotransferases (ALT or AST) ...
... into a leading diabetes management training center, not ... Afro-Asian countries//. The MV Hospital for Diabetes and ... Organization’s collaborating centre for diabetes research and training ... diverse countries as Cameroon, Tanzania, Myanmar, North Korea, ...
... rich in carbohydrates was very effective in maintaining weight loss ... be presented at the Australian //Institute of Food Science and ... conducted by the University of Melbourne research dietician Liz Delbridge ... for a period of 12 weeks. ,She and ...
... women with type 1 or 2 diabetes over a period ... of hip fracture among them//. This has helped to highlight ... population. ,According to Dr. Mohsen Janghorbani from Isfahan ... has not traditionally been considered a consequence of diabetes mellitus. ...
Cached Medicine News:Health News:Bone Marrow Cells Aid In Heart Repair 2Health News:Bone Marrow Cells Aid In Heart Repair 3Health News:India Approves Baraclude? (entecavir) For ,Treatment Of Chronic HEPATITIS B 2Health News:Diabetic Women Show Increased Risks of Hip Fracture 2